Sanofi, a global healthcare company, announced the opening of a new state-of-the-art pediatric and adult vaccine manufacturing facility at its Toronto Campus. Building upon its 110-year heritage, as the largest vaccine manufacturing site in Canada, Sanofi's expansion demonstrates the company's commitment to innovation and leadership in global public health. The new facility significantly increases capacity to meet growing Canadian and Global demand for pediatric and adult vaccines for pertussis (whooping cough), diphtheria and tetanus. These vaccines will be exported to 60 markets globally, protecting lives in Canada and around the world.